These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7778686)

  • 1. Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis.
    Makker SP; Widstrom R; Huang J
    Am J Pathol; 1995 Jun; 146(6):1481-7. PubMed ID: 7778686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
    Huang J; Makker SP
    Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
    Oleinikov AV; Makker SP
    J Pathol; 2000 Oct; 192(2):251-6. PubMed ID: 11004703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
    Oleinikov AV; Feliz BJ; Makker SP
    J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephritogenicity and immunocytochemical localization of the 70-kilodalton glycoprotein subunit (gp70) of Heymann antigen.
    Singh AK; Schwartz MM
    Clin Immunol Immunopathol; 1988 Jul; 48(1):61-77. PubMed ID: 3289803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
    Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
    J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp330 and RAP: the Heymann nephritis antigenic complex.
    Farquhar MG; Kerjaschki D; Lundstrom M; Orlando RA
    Ann N Y Acad Sci; 1994 Sep; 737():96-113. PubMed ID: 7944157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible ligand of serum origin for the kidney autoantigen of Heymann nephritis.
    Kanalas JJ; Makker SP
    J Immunol; 1988 Dec; 141(12):4152-7. PubMed ID: 3264306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
    Farquhar MG; Saito A; Kerjaschki D; Orlando RA
    J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory antigen of Heymann nephritis. II. Isolation of a 70,000 MW antigen from normal rat serum which cross-reacts with Heymann nephritis antigen.
    Singh AK; Schwartz MM
    Immunology; 1986 Nov; 59(3):451-8. PubMed ID: 3539772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
    Orlando RA; Kerjaschki D; Farquhar MG
    J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
    Singh AK; Kasinath BS
    Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the antigen (gp600) of Heymann nephritis.
    Makker SP; Singh AK
    Lab Invest; 1984 Mar; 50(3):287-93. PubMed ID: 6199583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of gp330 and gp330/alpha 2-macroglobulin receptor-associated protein in renal tubular differentiation.
    Abbate M; Bachinsky DR; McCluskey RT; Brown D
    J Am Soc Nephrol; 1994 Jun; 4(12):2003-15. PubMed ID: 7522607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-associated protein and members of the low density lipoprotein receptor family share a common epitope. An extended model for the development of passive Heymann nephritis.
    Hiesberger T; Hodits R; Ullrich R; Exner M; Kerjaschki D; Schneider WJ; Nimpf J
    J Biol Chem; 1996 Nov; 271(46):28792-7. PubMed ID: 8910522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gp330: receptor and autoantigen.
    Zheng G; Bachinsky DR; Abbate M; Andres G; Brown D; Stamenkovic I; Niles JL; McCluskey RT
    Ann N Y Acad Sci; 1994 Sep; 737():154-62. PubMed ID: 7944145
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein.
    Wu H; Zhang GY; Knight JF
    Clin Exp Immunol; 2000 Jul; 121(1):157-64. PubMed ID: 10886254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.